No Data
No Data
No Data
No Data
No Data
Express News | MEDIROM Healthcare Technologies Set To Acquire Japan Gene Medicine, Aiming For Subsidiarization
Moomoo 24/7Apr 3 02:26 ET
Medirom: Proposed Acquisition Price Is Y2.4B, Subject to Change After Due Diligence >MRM
Medirom: Proposed Acquisition Price Is Y2.4B, Subject to Change After Due Diligence >MRM
Dow JonesApr 2 23:32 ET
Medirom Healthcare: Executed MOU to Acquire All Shares in Japan Gene Medicine Corp., Make It a Subsidiary >MRM
Medirom Healthcare: Executed MOU to Acquire All Shares in Japan Gene Medicine Corp., Make It a Subsidiary >MRM
Dow JonesApr 2 23:31 ET
Medirom: Co. and Seller Agree to Negotiate to Enter Into Definitive Agreement by May 31 >MRM
Medirom: Co. and Seller Agree to Negotiate to Enter Into Definitive Agreement by May 31 >MRM
Dow JonesApr 2 23:31 ET
Announcement Execution of Memorandum of Understanding for Share Acquisition (Subsidiarization)
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. ("we", "our" or "us") hereby announces that we resolved, at a meeting of our Board of Directors held on March 29, 2024, to enter into a
GlobeNewswireApr 2 23:23 ET
Top 5 Consumer Stocks You May Want To Dump This Quarter
As of Jan. 2, 2024, three stocks in the consumer discretionary sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a moment
BenzingaJan 2 09:00 ET
No Data
No Data
jimmy the traderOP :
Dons hobby : Still here Jimmy Awin